Sharp
Sharp is a contract pharmaceutical services company offering comprehensive clinical and commercial packaging solutions, with facilities in the US, UK, Belgium, and the Netherlands.
Company Overview
Sharp is a company specializing in contract pharmaceutical services. Its offerings include a wide range of clinical and commercial services, from product development and contract manufacturing to packaging, labeling, storage, and distribution. With more than 70 years of experience in the clinical supply chain and contract pharmaceutical packaging, Sharp serves pharmaceutical and biotechnology clients through every phase of drug development and commercialization.
Clinical Services
Sharp provides comprehensive clinical services tailored to the pharmaceutical sector. These services encompass pharmaceutical product development, contract manufacturing, analytical services, comparator drug supply, primary packaging, labeling, secondary packaging, and clinical trials storage and distribution. The company also offers direct-to-patient solutions, ensuring streamlined drug delivery from clinical trials to end-users.
Commercial Packaging Solutions
Sharp offers extensive commercial packaging services, including blister packs, bottles, injectables, and vial labeling. They also provide specialized services such as autoinjector and pen assembly, pre-filled syringe assembly, and YpsoMate® device assembly. Other packaging services include small scale sterile fill-finish, oral thin film and transdermal patches, pouches, sachets, kitting, and gene therapy commercial packaging. Design services, serialization, and aggregation are also part of Sharp's offerings.
Global Reach and Facilities
Sharp operates a network of GMP facilities located in the United States, United Kingdom, Belgium, and the Netherlands. These facilities offer global reach, production scalability, and risk mitigation. Sharp's recent acquisitions and investments, including the purchase of Berkshire Sterile Manufacturing and expansion at the EU Heerenveen facility, enhance its capabilities in sterile injectable products and gene therapy packaging and distribution.
Sustainability and Community Initiatives
Committed to sustainability, Sharp participates in the Science Based Targets initiative (SBTi) to set and achieve greenhouse gas emissions reduction targets. The company supports community initiatives, including partnerships with UNICEF. Sharp integrates sustainability into its operational practices, aiming to minimize its environmental impact while contributing positively to the communities it serves.